| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $125.6M | +13.7% |
| R&D Expense | $239.4M | +5.2% |
| SG&A Expense | $63.6M | +4.0% |
| Operating Income | -$177.5M | +0.5% |
| Pre-tax Income | -$89.6M | +61.8% |
| Income Tax | $2.5M | +54.9% |
| Net Income | -$91.9M | +60.5% |
| EPS (Basic) | -$1.24 | +65.4% |
| EPS (Diluted) | -$1.24 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.1M | +32.3% |
| Accounts Receivable | $29.3M | -51.8% |
| Current Assets | $599.8M | +3.8% |
| Total Assets | $875.5M | -8.0% |
| Current Liabilities | $95.9M | +9.7% |
| Long-term Debt | $76.5M | -33.6% |
| Total Liabilities | $239.9M | -13.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$135.1M | +33.2% |
| Capital Expenditures | $3.1M | -48.3% |
| Investing Cash Flow | $140.0M | +1878.3% |
| Financing Cash Flow | $8.2M | -95.8% |
| Free Cash Flow | -$138.3M | +33.6% |
| +65.4% |
| Stockholders' Equity |
| $635.6M |
| -6.2% |